CN112603860A - 一种艾草舒敏修护面霜及其制备方法 - Google Patents
一种艾草舒敏修护面霜及其制备方法 Download PDFInfo
- Publication number
- CN112603860A CN112603860A CN202110161456.6A CN202110161456A CN112603860A CN 112603860 A CN112603860 A CN 112603860A CN 202110161456 A CN202110161456 A CN 202110161456A CN 112603860 A CN112603860 A CN 112603860A
- Authority
- CN
- China
- Prior art keywords
- wormwood
- parts
- allergy
- preparation
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 39
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 34
- 208000026935 allergic disease Diseases 0.000 title claims abstract description 34
- 230000008439 repair process Effects 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 241001435059 Artemisia argyi Species 0.000 title description 2
- 235000010894 Artemisia argyi Nutrition 0.000 title description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 79
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 77
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 77
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 77
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 77
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 77
- 239000000341 volatile oil Substances 0.000 claims abstract description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000000203 mixture Substances 0.000 claims abstract description 29
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 26
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 26
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 18
- 239000003921 oil Substances 0.000 claims abstract description 14
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 13
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 13
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 13
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 13
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 13
- 229960000458 allantoin Drugs 0.000 claims abstract description 13
- 150000001413 amino acids Chemical class 0.000 claims abstract description 13
- 239000010495 camellia oil Substances 0.000 claims abstract description 13
- 229940106189 ceramide Drugs 0.000 claims abstract description 13
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003906 humectant Substances 0.000 claims abstract description 13
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 13
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940032094 squalane Drugs 0.000 claims abstract description 13
- 239000011709 vitamin E Substances 0.000 claims abstract description 13
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 13
- 229940046009 vitamin E Drugs 0.000 claims abstract description 13
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 12
- 239000008367 deionised water Substances 0.000 claims abstract description 12
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 12
- 235000004866 D-panthenol Nutrition 0.000 claims abstract description 7
- 239000011703 D-panthenol Substances 0.000 claims abstract description 7
- 235000001014 amino acid Nutrition 0.000 claims abstract description 6
- 238000001816 cooling Methods 0.000 claims abstract description 6
- 239000011159 matrix material Substances 0.000 claims abstract description 6
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract 23
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 20
- 238000004821 distillation Methods 0.000 claims description 16
- 108010059892 Cellulase Proteins 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 229940106157 cellulase Drugs 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 5
- 238000001256 steam distillation Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 230000007815 allergy Effects 0.000 abstract description 4
- 238000002844 melting Methods 0.000 abstract description 3
- 230000008018 melting Effects 0.000 abstract description 3
- 240000006891 Artemisia vulgaris Species 0.000 description 74
- 230000003266 anti-allergic effect Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 11
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 4
- BAVONGHXFVOKBV-UHFFFAOYSA-N Carveol Chemical compound CC(=C)C1CC=C(C)C(O)C1 BAVONGHXFVOKBV-UHFFFAOYSA-N 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- BAVONGHXFVOKBV-ZJUUUORDSA-N (-)-trans-carveol Natural products CC(=C)[C@@H]1CC=C(C)[C@@H](O)C1 BAVONGHXFVOKBV-ZJUUUORDSA-N 0.000 description 2
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 229930007646 carveol Natural products 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000037339 Rare allergic disease Diseases 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- -1 alkanes compounds Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种艾草舒敏修护面霜,包括以下重量份数的原料:艾草植物精油3‑10份、山茶花油8‑15份、天然角鲨烷3‑8份、维生素E 2‑8份、神经酰胺3‑8份、烟酰胺3‑8份、维生素原B55‑10份、氨基酸保湿剂3‑10份、尿囊素0.3‑0.8份、乳化剂2‑7份,去离子水余量。面霜的具体制备方法为:将山茶花油、天然角鲨烷、维生素E混合,后加入乳化剂,融化得油相混合物;将神经酰胺、烟酰胺、维生素原B5、氨基酸保湿剂、尿囊素和去离子水混合得水相混合物;将水相混合物加至油相混合物中混合至白色乳状基质,自然冷却后上加入艾草植物精油得艾草舒敏修护面霜。本发明制备的艾草舒敏修护面霜具有抗过敏和舒缓修护皮肤的功效。
Description
技术领域
本发明涉及护肤品领域,具体涉及一种艾草舒敏修护面霜及其制备方法。
背景技术
随着人们饮食结构的变化、环境污染、生活和工作压力的增大,皮肤过敏患者日益增加。每逢气候转换、温差悬殊大或是换季时节也容易出现皮肤过敏的现象,特别是春天,柳絮和灰尘都会让脸部出现大面积的过敏。因此,寻求一些抗过敏和舒缓修护的护肤品十分必要,面霜自然是抗过敏护肤产品中常用的产品。然而目前市场上抗过敏面霜一般会添加有激素成分,长时间使用对人体危害极大,容易产生耐药性,也容易复发,因此人们对化妆品的要求越来越高,特别是产品的安全性,希望抗过敏化妆品具有很好的舒敏修护效果,同时是天然安全无刺激的。
针对上述市场情况,将有抗过敏功效的天然植物提取物添加到面霜中,赋予产品良好的抗过敏功效,将是抗过敏面霜的一个趋势,并为广大消费者首选或青睐。艾草又名艾蒿、冰台、医草等,属于菊科的一种多年生草本植物,植株有浓烈香气。艾草是我国劳动人民认识和使用较早的一种传统中草药,最早记载于《黄帝内经》,药用历史悠久。众所周知,我国民间自古就有在端午节“悬艾叶、食艾糕、饮艾酒、熏艾烟、洗艾澡”的各种用艾习俗,该用法直接接触人们皮肤,多年来却罕见过敏的报道,而流行的这样一句谚语:“家有三年艾,郎中不用来”说明艾草使用广泛的重要性和安全性。艾草产地分布广,除极干旱与高寒地区外,几乎遍及全国。据现代植物化学研究,艾草的主要成分是挥发油,为草绿色或浅黄色澄清油状液体,具有特殊香气,具有抗菌、消炎、抗过敏、抗氧化等药理活性。
发明内容
有鉴于此,为解决上述现有技术的不足,本发明的目的在于提供了一种艾草舒敏修护面霜及其制备方法,以解决上述现有技术存在的问题,具有抗过敏和舒缓修护敏感肌肤的双重功效,镇定收敛,美白保湿,抗皱抗氧化,不含化学防腐剂,天然温和。
为实现上述目的,本发明所采用的技术方案是:
一种艾草舒敏修护面霜,包括以下重量份数的原料:艾草植物精油3-10份、山茶花油8-15份、深海鱼鲛油3-8份、维生素E 2-8份、神经酰胺3-8份、烟酰胺3-8份、维生素原B55-10份、氨基酸保湿剂3-10份、尿囊素0.3-0.8份、乳化剂2-7份,去离子水余量。
一种艾草舒敏修护面霜的制备方法,具体步骤如下:
步骤一、将山茶花油、深海鱼鲛油、维生素E混合均匀,然后于40-70℃水浴条件下加入乳化剂,搅拌至材料全部融化,得油相混合物,备用;
步骤二、将神经酰胺、烟酰胺、维生素原B5、氨基酸保湿剂、尿囊素和适量去离子水混合,在40-70℃水浴条件下搅拌均匀,得水相混合物,备用;
步骤三、将水相混合物缓慢加至油相混合物中混合至呈均匀白色乳状基质后停止搅拌,自然冷却至室温;
步骤四、向步骤三混合物中加入艾草植物精油,搅拌均匀,即得艾草舒敏修护面霜。
进一步优化,所述步骤四中艾草植物精油的提取方法为:
步骤一、称取经过阴干的艾草地上部分的茎和叶作为艾草原材料,粉碎后用纤维素酶水溶液喷洒在艾草原材料上;
步骤二、将步骤一处理过的艾草原材料置于蒸馏瓶中,水蒸气蒸馏3-5小时,蒸馏速度为每秒1-2滴,得到艾草挥发油,备用;
步骤三、将步骤二得到的艾草挥发油采用乙酸乙酯萃取,收集上层萃取液,然后加入无水硫酸镁进行干燥,静置过夜并过滤,收集滤液,滤液经减压蒸除溶剂后,即得到艾草天然精油。
进一步优化,步骤一中所述的纤维素酶水溶液的质量浓度为0.15%。
进一步优化,步骤三中的减压蒸馏的真空度为0.090-0.095Mpa,水浴温度为45-52℃。
进一步优化,步骤三中乙酸乙酯的用量为艾草挥发油重量的1/3。
本发明的有益效果是:
1、本发明制备的艾草舒敏修护面霜中含有4-松油醇、香芹醇、红没药醇、紫苏醛多种抗过敏成分占精油含量的11%以上,具有抗过敏和舒缓修护皮肤的功效,增强皮肤屏障,镇定收敛,有令人愉快的芳香气味,其中抑菌成分又可作为天然防腐剂,安全有效;
2、艾叶中的挥发油具有抗过敏和局部收敛作用,艾草挥发油主要成分是单萜及其衍生物、倍半萜类及其衍生物、酮类、醇类、酸类以及烷烃类化合物,具有广泛的药理活性;
3、本发明制备的艾草舒敏修护面霜转化为具有抗过敏和舒缓修护功效的面霜,制备方法简单、原料来源广泛,成本低,制得的面霜抗敏收敛和舒缓修护效果显著,使用感天然温和、具有良好的抗氧化和美白保湿作用,与现有技术相比,本发明所制得的面霜细腻亲肤,透皮性好,易吸收,味道清新温和,美白抗氧化,有高效舒缓抗敏的功效,零添加化学防腐剂,安全有效,适用于易过敏和敏感性皮肤;
4、本发明制备的面霜采用山茶花油、天然角鲨烷、维生素原B5、氨基酸保湿剂、尿囊素作为滋润保湿成分,采用神经酰胺作为皮肤屏障成分,采用维生素E作为抗氧化成分,采用烟酰胺作为美白成分,另外还有乳化剂,该配方突出了所用各种成分与艾草精油的理化和药学功效的性能的兼容,制备的艾草舒敏修护面霜产品使用独特,检测指标均达到质量标准,熔点达到熔点45-55℃,挥发油量≥3.0%的优级品标准,其配方及制备方法工艺既能降低产品成本又保证产品的质量也符合其质量标准。
具体实施方式
下面给出具体实施例,对本发明的技术方案作进一步清楚、完整、详细地说明。本实施例是以本发明技术方案为前提的最佳实施例,但本发明的保护范围不限于下述的实施例。
实施例1
一种艾草舒敏修护面霜,所述面霜按照重量份数由以下原料制成:艾草植物精油3份、山茶花油8份、天然角鲨烷3份、维生素E 2份、神经酰胺3份、烟酰胺3份、维生素原B5 5份、氨基酸保湿剂3份、尿囊素0.3份、乳化剂2份,去离子水余量。
护手霜的具体制备方法为:
首先将山茶花油、天然角鲨烷、维生素E混合均匀,然后于40℃水浴条件下加入乳化剂,搅拌至材料全部融化,得油相混合物;将神经酰胺、烟酰胺、维生素原B5、氨基酸保湿剂、尿囊素和适量去离子水混合,在40℃水浴条件下搅拌均匀,得水相混合物;其次将水相混合物缓慢加至油相混合物中混合至呈均匀白色乳状基质后停止搅拌,自然冷却至室温后上加入艾草植物精油,搅拌均匀,即得艾草舒敏修护面霜。
其中,上述艾草植物精油的提取方法为:
步骤一、艾草自伏牛山脉的具茨山下辛店镇艾草基地采收,阴干后称取艾草地上部分的茎和叶作为艾草原材料,粉碎后用纤维素酶水溶液喷洒在艾草原材料上,纤维素酶水溶液的质量浓度为0.15%;
步骤二、将步骤一处理过的艾草原材料置于蒸馏瓶中,水蒸气蒸馏3小时,蒸馏速度为每秒1-2滴,得到艾草挥发油,备用;
步骤三、将步骤二得到的艾草挥发油采用乙酸乙酯萃取,乙酸乙酯的用量为艾草挥发油重量的1/3,收集上层萃取液,然后加入无水硫酸镁进行干燥,静置过夜并过滤,收集滤液,滤液经减压蒸除溶剂后,减压蒸馏的真空度为0.095Mpa,水浴温度为45℃,即得到艾草天然精油。
实施例2
一种艾草舒敏修护面霜,所述面霜按照重量份数由以下原料制成:艾草植物精油5份、山茶花油10份、天然角鲨烷5份、维生素E 3份、神经酰胺5份、烟酰胺5份、维生素原B5 6份、氨基酸保湿剂5份、尿囊素0.5份、乳化剂3份,去离子水余量。
艾草舒敏修护面霜的具体制备方法为:
首先将山茶花油、天然角鲨烷、维生素E混合均匀,然后于50℃水浴条件下加入乳化剂,搅拌至材料全部融化,得油相混合物;将神经酰胺、烟酰胺、维生素原B5、氨基酸保湿剂、尿囊素和适量去离子水混合,在40℃水浴条件下搅拌均匀,得水相混合物;其次将水相混合物缓慢加至油相混合物中混合至呈均匀白色乳状基质后停止搅拌,自然冷却至室温后上加入艾草植物精油,搅拌均匀,即得艾草舒敏修护面霜。
其中,上述艾草植物精油的提取方法为:
步骤一、艾草自伏牛山脉的具茨山下辛店镇艾草基地采收,阴干后称取艾草地上部分的茎和叶作为艾草原材料,粉碎后用纤维素酶水溶液喷洒在艾草原材料上,纤维素酶水溶液的质量浓度为0.15%;
步骤二、将步骤一处理过的艾草原材料置于蒸馏瓶中,水蒸气蒸馏5小时,蒸馏速度为每秒1-2滴,得到艾草挥发油,备用;
步骤三、将步骤二得到的艾草挥发油采用乙酸乙酯萃取,乙酸乙酯的用量为艾草挥发油重量的1/3,收集上层萃取液,然后加入无水硫酸镁进行干燥,静置过夜并过滤,收集滤液,滤液经减压蒸除溶剂后,减压蒸馏的真空度为0.092Mpa,水浴温度为50℃,即得到艾草天然精油。
实施例3
一种艾草舒敏修护面霜,包括以下重量份数的原料:艾草植物精油10份、山茶花油15份、天然角鲨烷8份、维生素E 8份、神经酰胺8份、烟酰胺8份、维生素原B5 10份、氨基酸保湿剂8份、尿囊素0.8份、乳化剂7份,去离子水余量;
艾草舒敏修护面霜的具体制备方法为:
首先将山茶花油、天然角鲨烷、维生素E混合均匀,然后于70℃水浴条件下加入乳化剂,搅拌至材料全部融化,得油相混合物;将神经酰胺、烟酰胺、维生素原B5、氨基酸保湿剂、尿囊素和适量去离子水混合,在40℃水浴条件下搅拌均匀,得水相混合物;其次将水相混合物缓慢加至油相混合物中混合至呈均匀白色乳状基质后停止搅拌,自然冷却至室温后上加入艾草植物精油,搅拌均匀,即得艾草舒敏修护面霜。
其中,艾草天然精油的提取方法为:
步骤一、艾草自伏牛山脉的具茨山下辛店镇艾草基地采收,阴干后称取艾草地上部分的茎和叶作为艾草原材料,粉碎后用纤维素酶水溶液喷洒在艾草原材料上,纤维素酶水溶液的质量浓度为0.15%;
步骤二、将步骤一处理过的艾草原材料置于蒸馏瓶中,水蒸气蒸馏4小时,蒸馏速度为每秒1-2滴,得到艾草挥发油,备用;
步骤三、将步骤二得到的艾草挥发油采用乙酸乙酯萃取,乙酸乙酯的用量为艾草挥发油重量的1/3,收集上层萃取液,然后加入无水硫酸镁进行干燥,静置过夜并过滤,收集滤液,滤液经减压蒸除溶剂后,减压蒸馏的真空度为0.090Mpa,水浴温度为52℃,即得到艾草天然精油。
通过GC-MS分析,艾草挥发油中共识别鉴定出24种有效成分,具体为如下表1所示,其中GC-MS分析仪器采用美国HP6890气相
HP5973N质谱联用及Nist98数据系统,毛细管柱采用型号DB-35MS,30.0m×250μm×0.30μm,载气为氦气,流速为1.0ml/min,分流比为5:1,EI电压为70ev,扫描质量范围为40~400,升温程序为80℃保持1min 4℃/min升至120℃保持5min,以3℃/min升至170℃保持2min,再以10℃/min升至280℃保持5min。
表1 艾草挥发油成分分析表
其中艾草植物挥发油中桉油精、樟脑、龙脑、α-水芹烯、莰烯、芳樟醇、丁香酚、柠檬烯具有抗菌消炎成分,占艾草精油含量的55.66%,具有抗菌消炎和保护皮肤的双重功效;4-松油醇、香芹醇、紫苏醛、红没药醇具有抗过敏成分,占艾草植物精油挥发油总含量的11.77%;β-石竹烯、香芹酚、马鞭草烯酮、β-榄香烯具有抗氧化成分,占挥发油总含量的13.27%;基于上述,本发明所制得的面霜细腻亲肤,透皮性好,易吸收,味道清新温和,美白抗氧化,有高效舒缓抗敏的功效,适用于易过敏和敏感性皮肤,并且具有熔点达到45-55℃,其配方及制备方法工艺既能降低产品成本又保证产品的质量也符合其质量标准。
以上显示和描述了本发明的主要特征、基本原理以及本发明的优点。本行业技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会根据实际情况有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (6)
1.一种艾草舒敏修护面霜,其特征在于:包括以下重量份数的原料:艾草植物精油3-10份、山茶花油8-15份、天然角鲨烷3-8份、维生素E 2-8份、神经酰胺3-8份、烟酰胺3-8份、维生素原B5 5-10份、氨基酸保湿剂3-10份、尿囊素0.3-0.8份、乳化剂2-7份,去离子水余量。
2.一种艾草舒敏修护面霜的制备方法,其特征在于:具体步骤如下:
步骤一、将山茶花油、天然角鲨烷、维生素E混合均匀,然后于40-70℃水浴条件下加入乳化剂,搅拌至材料全部融化,得油相混合物,备用;
步骤二、将神经酰胺、烟酰胺、维生素原B5、氨基酸保湿剂、尿囊素和适量去离子水混合,在40-70℃水浴条件下搅拌均匀,得水相混合物,备用;
步骤三、将水相混合物缓慢加至油相混合物中混合至呈均匀白色乳状基质后停止搅拌,自然冷却至室温;
步骤四、向步骤三混合物中加入艾草植物精油,搅拌均匀,即得艾草舒敏修护面霜。
3.如权利要求2所述的一种艾草舒敏修护面霜的制备方法,其特征在于:所述步骤四中艾草植物精油的提取方法为:
步骤一、称取经过阴干的艾草地上部分的茎和叶作为艾草原材料,粉碎后用纤维素酶水溶液喷洒在艾草原材料上;
步骤二、将步骤一处理过的艾草原材料置于蒸馏瓶中,水蒸气蒸馏3-5小时,蒸馏速度为每秒1-2滴,得到艾草挥发油,备用;
步骤三、将步骤二得到的艾草挥发油采用乙酸乙酯萃取,收集上层萃取液,然后加入无水硫酸镁进行干燥,静置过夜并过滤,收集滤液,滤液经减压蒸除溶剂后,即得到艾草天然精油。
4.如权利要求3所述的一种艾草舒敏修护面霜的制备方法,其特征在于:步骤一中所述的纤维素酶水溶液的质量浓度为0.15%。
5.如权利要求3所述的一种艾草舒敏修护面霜的制备方法,其特征在于:步骤三中的减压蒸馏的真空度为0.090-0.095Mpa,水浴温度为45-52℃。
6.如权利要求3所述的一种艾草舒敏修护面霜的制备方法,其特征在于:步骤三中乙酸乙酯的用量为艾草挥发油重量的1/3。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110161456.6A CN112603860A (zh) | 2021-02-05 | 2021-02-05 | 一种艾草舒敏修护面霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110161456.6A CN112603860A (zh) | 2021-02-05 | 2021-02-05 | 一种艾草舒敏修护面霜及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112603860A true CN112603860A (zh) | 2021-04-06 |
Family
ID=75254293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110161456.6A Pending CN112603860A (zh) | 2021-02-05 | 2021-02-05 | 一种艾草舒敏修护面霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112603860A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116236412A (zh) * | 2023-02-28 | 2023-06-09 | 江苏更美科技有限公司 | 一种多肽修护面霜及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108379189A (zh) * | 2018-04-11 | 2018-08-10 | 晋双寿 | 一种护肤霜及其制备方法 |
CN110179741A (zh) * | 2019-07-08 | 2019-08-30 | 江苏康地源生态农场有限公司 | 一种天然保湿的艾草护肤霜及其制备方法 |
-
2021
- 2021-02-05 CN CN202110161456.6A patent/CN112603860A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108379189A (zh) * | 2018-04-11 | 2018-08-10 | 晋双寿 | 一种护肤霜及其制备方法 |
CN110179741A (zh) * | 2019-07-08 | 2019-08-30 | 江苏康地源生态农场有限公司 | 一种天然保湿的艾草护肤霜及其制备方法 |
Non-Patent Citations (1)
Title |
---|
李铭泽等: "《美肤拍档》", 31 January 2016, pages: 92 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116236412A (zh) * | 2023-02-28 | 2023-06-09 | 江苏更美科技有限公司 | 一种多肽修护面霜及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101518506B (zh) | 用于抗过敏护肤品的芳香植物提取液 | |
CN108096117B (zh) | 一种组合物及其制备方法和应用 | |
CN105055244A (zh) | 有机天然植物防腐剂 | |
KR20080002279A (ko) | 아토피 증상 개선의 효과가 있는 입술용 화장료 조성물 | |
CN106727032A (zh) | 一种多功能纯露及其制备方法 | |
Dai et al. | Honey in traditional Chinese medicine: A guide to future applications of NADES to medicines | |
CN112656715A (zh) | 一种艾草润肤抗菌护手霜及其制备方法 | |
KR100898182B1 (ko) | 화장료 조성물 | |
CN112603860A (zh) | 一种艾草舒敏修护面霜及其制备方法 | |
KR20120009554A (ko) | 항산화 및 항알레르기 효과를 갖는 허브 추출물 함유하는 화장료 조성물 | |
JP4243202B2 (ja) | シワ改善用皮膚外用剤 | |
CN109620779A (zh) | 一种祛痘保湿美容面霜及其制备方法 | |
AU614740B2 (en) | Beauty preparations having anti-fading effect and a process for preparing the same | |
CN112891504A (zh) | 一种以生姜药渣为基材的四季护肤防疫生姜膏及制备方法 | |
CN112656714A (zh) | 一种艾草舒敏抗炎精华液及其制备方法 | |
CN110051591A (zh) | 一种含有金莲花纯露的喷雾剂及其制备和应用 | |
KR950000686B1 (ko) | 호장근 추출물을 함유한 미백화장료 | |
CN115518127A (zh) | 一种抑菌抗炎消肿止痒乳膏及其制备方法 | |
CN100356937C (zh) | 一种祛风通络、舒筋止痛的外用药物制剂 | |
KR102282642B1 (ko) | 5가지 방향성 식물과 5가지 생약소재의 복합추출물을 함유하는 화장료 조성물 | |
CN112972332B (zh) | 玫瑰美白精华液及其制备方法 | |
KR20090075950A (ko) | 난치성 아토피성 피부염 치료용 조성물 | |
KR102127771B1 (ko) | 한방복합추출물을 유효성분으로 하는 항산화, 항염증, 항노화 또는 피부진정을 위한 조성물 | |
KR101382137B1 (ko) | 히어리 및 얼레지의 혼합 추출물을 포함하는 조성물 | |
CN111870542A (zh) | 基于光甘草定微分子纳米美白乳制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210406 |